Thu, Apr 25, 2024
Volume 6, Issue 2 (12-2019)
vacres 2019, 6(2): 37-41 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Malekan M, Siadat S D, Aghasadeghi M, Shahrokhi N, Eybpoosh S, Afshari E et al . Assessment of PhtD C-Terminal Immunogenicity by Opsonophagocytosis Assay (OPA) with OMVs as Adjuvants. vacres 2019; 6 (2) :37-41
URL: http://vacres.pasteur.ac.ir/article-1-175-en.html
URL: http://vacres.pasteur.ac.ir/article-1-175-en.html
Mohammadali Malekan 
, Seyed Davar Siadat , Mohammadreza Aghasadeghi , Nader Shahrokhi , Sana Eybpoosh , Elnaz Afshari , Seyed fazlollah Mousavi *
, Seyed Davar Siadat , Mohammadreza Aghasadeghi , Nader Shahrokhi , Sana Eybpoosh , Elnaz Afshari , Seyed fazlollah Mousavi *
Department of Microbiology, Pasteur Institute of Iran, Tehran, Iran
Abstract: (2660 Views)
Introduction: Streptococcus pneumoniae causes invasive and non-invasive diseases in children and adults. Currently, there are two types of pneumococcal vaccines: 23-valent pneumococcal polysaccharide vaccine and 13-valent pneumococcal conjugate vaccine which have caused many failures. Therefore, a new generation of pneumococcal vaccines is being pursued. Methods: An improved version of our previous study was performed using recombinant C-terminal of pneumococcal polyhistidine triad protein D (PhtD-C) as a vaccine antigen. The antigen was combined with meningococcal outer membrane vesicle (OMV) and alum as adjuvants to immunize BALB/c mice intraperitoneally. The generated total IgG, specific IgG, IgG1 and IgG2a antibodies and the killing ability of pneumococci by an opsonophagocytosis assay were then assayed. Results: Immunization by 30 µg PhtD-C and 50 µg OMV as an adjuvant, induced higher amounts of functional antibodies compared to our previous study while killing 50-55% of pneumococci cells. Conclusion: At optimized concentrations, PhtD-C and meningococcal OMV could be considered as a potent immunogens and the induced specific IgGs were effective and functional for killing pneumococci.
Type of Study: Research |
Subject:
Vaccine development, efficacy and safety evaluation
Received: 2020/02/29
Received: 2020/02/29
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.